• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于影像组学的病灶间关系网络用于描述前列腺癌中[F]FMCH PET/CT成像表型

Radiomics-Based Inter-Lesion Relation Network to Describe [F]FMCH PET/CT Imaging Phenotypes in Prostate Cancer.

作者信息

Cavinato Lara, Sollini Martina, Ragni Alessandra, Bartoli Francesco, Zanca Roberta, Pasqualetti Francesco, Marciano Andrea, Ieva Francesca, Erba Paola Anna

机构信息

MOX-Modeling and Scientific Computing, Department of Mathematics, Politecnico di Milano, p.zza Leonardo da Vinci 32, 20133 Milan, Italy.

Department of Biomedical Sciences, Humanitas University, Via R. Levi Montalcini 4, 20090 Pieve Emanuele, Italy.

出版信息

Cancers (Basel). 2023 Jan 29;15(3):823. doi: 10.3390/cancers15030823.

DOI:10.3390/cancers15030823
PMID:36765781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9913254/
Abstract

Advanced image analysis, including radiomics, has recently acquired recognition as a source of biomarkers, although there are some technical and methodological challenges to face for its application in the clinic. Among others, proper phenotyping of metastatic or systemic disease where multiple lesions coexist is an issue, since each lesion contributes to characterization of the disease. Therefore, the radiomic profile of each lesion should be modeled into a more complex architecture able to reproduce each "unit" (lesion) as a part of the "entire" (patient). This work aimed to characterize intra-tumor heterogeneity underpinning metastatic prostate cancer using an exhaustive innovative approach which consist of a i) feature transformation method to build an agnostic (i.e., irrespective of pre-existence knowledge, experience, and expertise) radiomic profile of lesions extracted from [F]FMCH PET/CT, ii) qualitative assessment of intra-tumor heterogeneity of patients, iii) quantitative representation of the intra-tumor heterogeneity of patients in terms of the relationship between their lesions' profiles, to be associated with prognostic factors. We confirmed that metastatic prostate cancer patients encompassed lesions with different radiomic profiles that exhibited intra-tumor radiomic heterogeneity and that the presence of many radiomic profiles within the same patient impacted the outcome.

摘要

包括放射组学在内的先进图像分析最近已被认可为生物标志物的来源,尽管其在临床应用中面临一些技术和方法上的挑战。其中,在存在多个病灶的转移性或全身性疾病的正确表型分析是一个问题,因为每个病灶都对疾病的特征有贡献。因此,每个病灶的放射组学特征应被建模为一个更复杂的结构,能够将每个“单元”(病灶)作为“整体”(患者)的一部分进行再现。这项工作旨在使用一种详尽的创新方法来表征转移性前列腺癌的肿瘤内异质性,该方法包括:i)一种特征转换方法,用于构建从[F]FMCH PET/CT中提取的病灶的不可知(即不考虑先验知识、经验和专业知识)放射组学特征;ii)对患者肿瘤内异质性的定性评估;iii)根据患者病灶特征之间的关系对患者肿瘤内异质性进行定量表示,以便与预后因素相关联。我们证实,转移性前列腺癌患者的病灶具有不同的放射组学特征,表现出肿瘤内放射组学异质性,并且同一患者体内存在多种放射组学特征会影响预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/af067b2afd44/cancers-15-00823-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/903355991300/cancers-15-00823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/316a47dc201c/cancers-15-00823-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/ccdb574be2e1/cancers-15-00823-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/060ebe9acc93/cancers-15-00823-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/0c6660b008d6/cancers-15-00823-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/6496e5f29289/cancers-15-00823-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/b7908badc52e/cancers-15-00823-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/e14be688341d/cancers-15-00823-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/af067b2afd44/cancers-15-00823-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/903355991300/cancers-15-00823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/316a47dc201c/cancers-15-00823-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/ccdb574be2e1/cancers-15-00823-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/060ebe9acc93/cancers-15-00823-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/0c6660b008d6/cancers-15-00823-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/6496e5f29289/cancers-15-00823-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/b7908badc52e/cancers-15-00823-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/e14be688341d/cancers-15-00823-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51b/9913254/af067b2afd44/cancers-15-00823-g009.jpg

相似文献

1
Radiomics-Based Inter-Lesion Relation Network to Describe [F]FMCH PET/CT Imaging Phenotypes in Prostate Cancer.基于影像组学的病灶间关系网络用于描述前列腺癌中[F]FMCH PET/CT成像表型
Cancers (Basel). 2023 Jan 29;15(3):823. doi: 10.3390/cancers15030823.
2
[F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer.[F]FMCH PET/CT生物标志物及相似性分析以完善寡转移前列腺癌的定义
EJNMMI Res. 2021 Nov 27;11(1):119. doi: 10.1186/s13550-021-00858-8.
3
Metastatic Lung Adenocarcinomas: Development and Evaluation of Radiomic-Based Methods to Measure Baseline Intra-Patient Inter-Tumor Lesion Heterogeneity.转移性肺腺癌:基于影像组学的方法用于测量患者内肿瘤间病变异质性的开发与评估
J Imaging Inform Med. 2025 Feb;38(1):148-164. doi: 10.1007/s10278-024-01163-1. Epub 2024 Jul 17.
4
The Triple-Tracer strategy against Metastatic PrOstate cancer (3TMPO) study protocol.三示踪剂策略治疗转移性前列腺癌(3TMPO)研究方案。
BJU Int. 2022 Sep;130(3):314-322. doi: 10.1111/bju.15621. Epub 2021 Nov 11.
5
Predictive Power of a Radiomic Signature Based on F-FDG PET/CT Images for EGFR Mutational Status in NSCLC.基于F-FDG PET/CT图像的放射组学特征对非小细胞肺癌EGFR突变状态的预测能力
Front Oncol. 2019 Oct 15;9:1062. doi: 10.3389/fonc.2019.01062. eCollection 2019.
6
Improved Prognosis of Treatment Failure in Cervical Cancer with Nontumor PET/CT Radiomics.非肿瘤 PET/CT 影像组学可改善宫颈癌治疗失败的预后
J Nucl Med. 2022 Jul;63(7):1087-1093. doi: 10.2967/jnumed.121.262618. Epub 2021 Oct 28.
7
Analysis of Cross-Combinations of Feature Selection and Machine-Learning Classification Methods Based on [F]F-FDG PET/CT Radiomic Features for Metabolic Response Prediction of Metastatic Breast Cancer Lesions.基于[F]F-FDG PET/CT影像组学特征的特征选择与机器学习分类方法交叉组合用于转移性乳腺癌病灶代谢反应预测的分析
Cancers (Basel). 2022 Jun 14;14(12):2922. doi: 10.3390/cancers14122922.
8
Plausibility and redundancy analysis to select FDG-PET textural features in non-small cell lung cancer.用于选择非小细胞肺癌中FDG-PET纹理特征的合理性和冗余性分析
Med Phys. 2021 Mar;48(3):1226-1238. doi: 10.1002/mp.14684. Epub 2021 Feb 6.
9
Methodological framework for radiomics applications in Hodgkin's lymphoma.霍奇金淋巴瘤中放射组学应用的方法学框架。
Eur J Hybrid Imaging. 2020 Jun 1;4(1):9. doi: 10.1186/s41824-020-00078-8.
10
Additional Value of PET Radiomic Features for the Initial Staging of Prostate Cancer: A Systematic Review from the Literature.PET 影像组学特征在前列腺癌初始分期中的附加价值:文献系统评价
Cancers (Basel). 2021 Nov 30;13(23):6026. doi: 10.3390/cancers13236026.

引用本文的文献

1
Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanoma.转移性黑色素瘤患者对免疫疗法和BRAF靶向疗法反应的患者及器官间异质性的放射组学分析。
J Immunother Cancer. 2025 Feb 12;13(2):e009568. doi: 10.1136/jitc-2024-009568.
2
Predicting survival, neurotoxicity and response in B-cell lymphoma patients treated with CAR-T therapy using an imaging features-based model.使用基于成像特征的模型预测接受CAR-T疗法治疗的B细胞淋巴瘤患者的生存率、神经毒性和反应。
EJNMMI Res. 2024 Nov 20;14(1):113. doi: 10.1186/s13550-024-01172-9.
3
Radiomic-Based Approaches in the Multi-metastatic Setting: A Quantitative Review.

本文引用的文献

1
Joint EANM/SNMMI guideline on radiomics in nuclear medicine : Jointly supported by the EANM Physics Committee and the SNMMI Physics, Instrumentation and Data Sciences Council.核医学影像组学 EANM/SNMMI 指南:由 EANM 物理委员会和 SNMMI 物理、仪器和数据科学委员会共同支持。
Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):352-375. doi: 10.1007/s00259-022-06001-6. Epub 2022 Nov 3.
2
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival.基于 PET/CT 的肿块型肝内胆管细胞癌影像组学可提高病理数据和生存预测的准确性。
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3387-3400. doi: 10.1007/s00259-022-05765-1. Epub 2022 Mar 26.
3
多转移灶情况下基于影像组学的方法:定量综述
medRxiv. 2024 Jul 5:2024.07.04.24309964. doi: 10.1101/2024.07.04.24309964.
4
Radiomic-based prediction of lesion-specific systemic treatment response in metastatic disease.基于放射组学的转移性疾病中特定病变的全身性治疗反应预测。
Comput Med Imaging Graph. 2024 Sep;116:102413. doi: 10.1016/j.compmedimag.2024.102413. Epub 2024 Jun 25.
5
Radiomic-Based Prediction of Lesion-Specific Systemic Treatment Response in Metastatic Disease.基于影像组学的转移性疾病中病变特异性系统治疗反应预测
medRxiv. 2024 Aug 13:2023.09.22.23294942. doi: 10.1101/2023.09.22.23294942.
[F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer.
[F]FMCH PET/CT生物标志物及相似性分析以完善寡转移前列腺癌的定义
EJNMMI Res. 2021 Nov 27;11(1):119. doi: 10.1186/s13550-021-00858-8.
4
Contrast Administration Impacts CT-Based Radiomics of Colorectal Liver Metastases and Non-Tumoral Liver Parenchyma Revealing the "Radiological" Tumour Microenvironment.对比剂注射对结直肠癌肝转移和非肿瘤性肝实质的基于CT的影像组学有影响,揭示了“放射学”肿瘤微环境。
Diagnostics (Basel). 2021 Jun 25;11(7):1162. doi: 10.3390/diagnostics11071162.
5
Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology.人工智能与混合成像:肿瘤个性化医疗的最佳匹配
Eur J Hybrid Imaging. 2020 Dec 9;4(1):24. doi: 10.1186/s41824-020-00094-8.
6
Methodological framework for radiomics applications in Hodgkin's lymphoma.霍奇金淋巴瘤中放射组学应用的方法学框架。
Eur J Hybrid Imaging. 2020 Jun 1;4(1):9. doi: 10.1186/s41824-020-00078-8.
7
Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers.将放射组学纳入临床试验:欧洲放射学会专家共识,涉及数据驱动与生物学驱动定量生物标志物的考虑因素。
Eur Radiol. 2021 Aug;31(8):6001-6012. doi: 10.1007/s00330-020-07598-8. Epub 2021 Jan 25.
8
Climbing the steps of the evidence-based medicine pyramid: highlights from Annals of Nuclear Medicine 2019.攀登循证医学金字塔的台阶:2019 年《核医学年鉴》的亮点。
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1293-1301. doi: 10.1007/s00259-020-05073-6. Epub 2020 Nov 4.
9
Radiomics in medical imaging-"how-to" guide and critical reflection.医学影像中的放射组学——“操作指南”与批判性思考
Insights Imaging. 2020 Aug 12;11(1):91. doi: 10.1186/s13244-020-00887-2.
10
Interdisciplinarity: An essential requirement for translation of radiomics research into clinical practice -a systematic review focused on thoracic oncology.跨学科性:将放射组学研究转化为临床实践的必要要求——一项聚焦于胸部肿瘤学的系统综述。
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 May-Jun;39(3):146-156. doi: 10.1016/j.remn.2019.10.003. Epub 2020 Apr 8.